UY30356A1 - Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos. - Google Patents

Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.

Info

Publication number
UY30356A1
UY30356A1 UY30356A UY30356A UY30356A1 UY 30356 A1 UY30356 A1 UY 30356A1 UY 30356 A UY30356 A UY 30356A UY 30356 A UY30356 A UY 30356A UY 30356 A1 UY30356 A1 UY 30356A1
Authority
UY
Uruguay
Prior art keywords
oxobutil
trifluorometil
metil
benzamide
fluorophenyl
Prior art date
Application number
UY30356A
Other languages
English (en)
Inventor
Johan Johansson
Carl-Gustav Sigfridsson
Anders Johansson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38723558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30356(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY30356A1 publication Critical patent/UY30356A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

La presente invencinn se refiere a nuevos compuestosde fnrmula I, a composiciones farmaccuticas que contienen dichos compuestos, y al uso de dichos compuestos en terapia. La presente invencinn se refiere asimismo a procedimientos para la preparacinn de compuestos de fnrmula I.
UY30356A 2006-05-18 2007-05-16 Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos. UY30356A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80157706P 2006-05-18 2006-05-18

Publications (1)

Publication Number Publication Date
UY30356A1 true UY30356A1 (es) 2008-01-02

Family

ID=38723558

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30356A UY30356A1 (es) 2006-05-18 2007-05-16 Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.

Country Status (24)

Country Link
US (1) US8106208B2 (es)
EP (1) EP2024354B1 (es)
JP (1) JP5196381B2 (es)
KR (1) KR101429779B1 (es)
CN (1) CN101472910B (es)
AR (1) AR060956A1 (es)
AT (1) ATE525355T1 (es)
AU (1) AU2007253666B2 (es)
BR (1) BRPI0712405A2 (es)
CA (1) CA2652443C (es)
DK (1) DK2024354T3 (es)
ES (1) ES2373335T3 (es)
HK (1) HK1121758A1 (es)
IL (1) IL195197A (es)
MX (1) MX2008014686A (es)
MY (1) MY147474A (es)
NO (1) NO20084674L (es)
PL (1) PL2024354T3 (es)
PT (1) PT2024354E (es)
RU (1) RU2439067C2 (es)
TW (1) TW200813006A (es)
UY (1) UY30356A1 (es)
WO (1) WO2007136324A1 (es)
ZA (1) ZA200809909B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR057828A1 (es) * 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
CA2663280A1 (en) * 2006-09-14 2008-03-20 Neuromed Pharmaceuticals Ltd. Diaryl piperidine compounds as calcium channel blockers
EP2125711B1 (en) * 2007-03-08 2013-11-06 Albireo Ab 3-phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease
WO2009135842A1 (en) 2008-05-08 2009-11-12 Evotec Neurosciences Gmbh Azetidines and cyclobutanes as histamine h3 receptor antagonists
WO2012054716A1 (en) * 2010-10-22 2012-04-26 Janssen Pharmaceutica Nv. Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
CA2849779A1 (en) * 2011-09-30 2013-04-04 Janssen Pharmaceutica Nv Crystalline hydrochloride salt of (1- (4 -fluorophenyl) - 1h - indol - 5 - yl) - (3- (4- (thiazole - 2 - carbonyl) piperazin-1 - yl) az etidin- 1 -yl) methanone and its use in the treatment of pain and metabolic disorders
CN104529833B (zh) * 2014-12-10 2016-04-20 广东东阳光药业有限公司 取代的环丁烷羧酸类化合物及其用途
KR102476938B1 (ko) 2017-12-07 2022-12-13 기초과학연구원 핫전자 기반의 산화물-금속 하이브리드 역촉매

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310066D0 (en) 1993-05-17 1993-06-30 Zeneca Ltd Alkyl substituted heterocycles
GB9310713D0 (en) 1993-05-24 1993-07-07 Zeneca Ltd Aryl substituted heterocycles
GB9317104D0 (en) 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
GB9322643D0 (en) 1993-11-03 1993-12-22 Zeneca Ltd Lactam derivatives
GB9325074D0 (en) 1993-12-07 1994-02-02 Zeneca Ltd Bicyclic heterocycles
TW432061B (en) 1994-08-09 2001-05-01 Pfizer Res & Dev Lactams
GB9502644D0 (en) 1995-02-10 1995-03-29 Zeneca Ltd Heterocyclic derivatives
GB9600235D0 (en) 1996-01-05 1996-03-06 Pfizer Ltd Therapeutic agents
GB9601202D0 (en) 1996-01-22 1996-03-20 Pfizer Ltd Piperidones
GB9601697D0 (en) 1996-01-27 1996-03-27 Pfizer Ltd Therapeutic agents
GB9601680D0 (en) 1996-01-27 1996-03-27 Pfizer Ltd Therapeutic agents
GB9714129D0 (en) 1997-07-04 1997-09-10 Pfizer Ltd Azetidines
GB9812037D0 (en) 1998-06-04 1998-07-29 Pfizer Ltd Piperidones
CN1309638A (zh) 1998-07-10 2001-08-22 阿斯特拉曾尼卡有限公司 作为神经激肽受体拮抗剂的n－取代的萘甲酰胺
GB9922521D0 (en) 1998-10-07 1999-11-24 Zeneca Ltd Compounds
GB9922519D0 (en) 1998-10-07 1999-11-24 Zeneca Ltd Compounds
GB9924141D0 (en) 1998-10-30 1999-12-15 Zeneca Ltd Treatment of gastric asthma
GB9826941D0 (en) 1998-12-09 1999-02-03 Zeneca Pharmaceuticals Compounds
SE0004827D0 (sv) 2000-12-22 2000-12-22 Astrazeneca Ab Therapeutic compounds
SE0103795D0 (sv) 2001-11-02 2001-11-02 Astrazeneca Ab Compounds and method for the treatment of överactive bladder
TW200508221A (en) * 2003-06-13 2005-03-01 Astrazeneca Ab New azetidine compounds
CN101203511A (zh) * 2005-06-23 2008-06-18 阿斯利康(瑞典)有限公司 作为神经激肽受体拮抗剂用于治疗胃肠疾病的新氮杂环丁烷衍生物
WO2006137791A1 (en) * 2005-06-23 2006-12-28 Astrazeneca Ab New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
AR057828A1 (es) * 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
AR056087A1 (es) * 2005-09-29 2007-09-19 Astrazeneca Ab Derivados de azetidina como antagonistas de receptores de neuroquina nk

Also Published As

Publication number Publication date
CA2652443A1 (en) 2007-11-29
IL195197A (en) 2013-10-31
EP2024354A4 (en) 2009-11-11
ES2373335T3 (es) 2012-02-02
US20070270398A1 (en) 2007-11-22
AR060956A1 (es) 2008-07-23
NO20084674L (no) 2009-01-29
EP2024354B1 (en) 2011-09-21
DK2024354T3 (da) 2012-01-16
PT2024354E (pt) 2011-12-19
KR20090018926A (ko) 2009-02-24
JP5196381B2 (ja) 2013-05-15
RU2008149927A (ru) 2010-06-27
MY147474A (en) 2012-12-14
ATE525355T1 (de) 2011-10-15
WO2007136324A1 (en) 2007-11-29
US8106208B2 (en) 2012-01-31
CN101472910B (zh) 2014-03-26
EP2024354A1 (en) 2009-02-18
PL2024354T3 (pl) 2012-02-29
HK1121758A1 (en) 2009-04-30
TW200813006A (en) 2008-03-16
KR101429779B1 (ko) 2014-08-19
BRPI0712405A2 (pt) 2012-10-16
ZA200809909B (en) 2009-08-26
IL195197A0 (en) 2009-08-03
MX2008014686A (es) 2009-02-10
RU2439067C2 (ru) 2012-01-10
CA2652443C (en) 2014-01-14
JP2009537516A (ja) 2009-10-29
AU2007253666B2 (en) 2012-03-15
CN101472910A (zh) 2009-07-01
AU2007253666A1 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
CR11857A (es) Compuestos pirazolicos 436
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
UY29818A1 (es) Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
ECSP088246A (es) Nuevos derivados de benzotiazolona
UY28342A1 (es) Nuevos compuestos
ECSP066541A (es) Nuevos derivados de piridazin-3(2h)-ona
DOP2012000310A (es) Morfolinopirimidinas y su uso en terapia
UY32203A (es) Amino pirimidinas y su uso en terapia
UY30610A1 (es) Moduladores de mglur5
GT200600258A (es) Derivados de n-(piridin-2-il)-sulfonamida
UY30824A1 (es) Nuevos derivados de idazolil éster o amida, composiciones farmacéuticas conteniéndolas, procesos de preparacion y aplicaciones.
ECSP099750A (es) Imidazoquinolinas con propiedades inmunomoduladoras
UY29893A1 (es) Derivados de pirazina
UY31046A1 (es) Derivados sustituidos de n-(3,4-dihidro-2h-cromen-3-il)formamida y n-(1, 2,3 ,4-tetrahidronaftalen-2-il)formamida, sales de los mismos, composiciones que los contienen, procedimientos para su preparacion y aplicaciones
ECSP055671A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa
BRPI0407811A (pt) composto derivados de pirazolopiridina, processo para a preparação dos mesmos, composição farmacêutica e respectivos uso
UY29360A1 (es) Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones.
CR11106A (es) Inhibidores de cinasa p710 s6
UY30356A1 (es) Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.
UY30048A1 (es) Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
BRPI0606964A2 (pt) pirrolidinas e piperidinas derivadas do acetileno para uso como antagonistas de mglur5
UY27852A1 (es) Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
UY29003A1 (es) Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20120606